Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
- PMID: 12079901
- PMCID: PMC1754144
- DOI: 10.1136/ard.61.7.608
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
Abstract
Background: Antibodies against cyclic citrullinated peptide (anti-CCP) are considered to be specific for rheumatoid arthritis (RA).
Objective: To assess the clinical significance of anti-CCP in a cohort of patients with juvenile idiopathic arthritis (JIA).
Methods: Anti-CCP were tested by an enzyme linked immunosorbent assay (ELISA) in serum samples from 109 patients with JIA (30 boys, 79 girls), with a mean age of 8.7 years (range 0.6-20.3) and mean disease duration of 3.6 years (range 3 months to 15.6 years). As control groups, anti-CCP were also tested in sera of 30 healthy children, 25 patients with juvenile onset systemic lupus erythematosus (SLE), and 50 adult patients (30 with RA, 20 with SLE).
Results: Positive anti-CCP values were found in sera of two patients with JIA (2%), one with polyarthritis, and one with oligoarthritis. Statistical analysis showed that anti-CCP were not associated with the presence of antinuclear antibodies, raised erythrocyte sedimentation rate, or erosions. In the control groups, none of the patients with juvenile onset SLE and only one of 20 adults with SLE were positive for anti-CCP, but 19/30 (63%) adults with RA showed anti-CCP positivity.
Conclusions: Anti-CCP can be detected in children with JIA, but are less frequently present than in adults with RA.
Figures


Similar articles
-
Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.J Rheumatol. 2004 Sep;31(9):1829-33. J Rheumatol. 2004. PMID: 15338508
-
Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.Indian J Pediatr. 2010 Jan;77(1):41-4. doi: 10.1007/s12098-010-0006-4. Epub 2010 Feb 5. Indian J Pediatr. 2010. PMID: 20135267
-
Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.Immunol Invest. 2008;37(8):849-57. doi: 10.1080/08820130802438057. Immunol Invest. 2008. PMID: 18991100
-
Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology.Curr Rheumatol Rep. 2008 Apr;10(2):156-63. doi: 10.1007/s11926-008-0027-4. Curr Rheumatol Rep. 2008. PMID: 18460272 Review.
-
Autoantibody profile in juvenile chronic arthritis.Ann Rheum Dis. 1988 Mar;47(3):178-82. doi: 10.1136/ard.47.3.178. Ann Rheum Dis. 1988. PMID: 3281608 Free PMC article. Review.
Cited by
-
B-cell pathology in juvenile idiopathic arthritis.Arthritis. 2010;2010:759868. doi: 10.1155/2010/759868. Epub 2010 Dec 2. Arthritis. 2010. PMID: 22076178 Free PMC article.
-
Onset of polyarticular juvenile idiopathic arthritis with both anti-cyclic citrullinated peptide antibodies and rheumatoid factor in a 3-year-old girl.Pediatr Rheumatol Online J. 2012 Dec 13;10(1):41. doi: 10.1186/1546-0096-10-41. Pediatr Rheumatol Online J. 2012. PMID: 23237242 Free PMC article.
-
Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis.Pediatr Rheumatol Online J. 2013 Aug 29;11(1):31. doi: 10.1186/1546-0096-11-31. Pediatr Rheumatol Online J. 2013. PMID: 23987731 Free PMC article.
-
Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).Pediatr Rheumatol Online J. 2014 Jun 11;12:22. doi: 10.1186/1546-0096-12-22. eCollection 2014. Pediatr Rheumatol Online J. 2014. PMID: 24944545 Free PMC article.
-
The role of anti-cyclic cytrullinate antibodies testing in rheumatoid arthritis.Clin Rev Allergy Immunol. 2008 Feb;34(1):45-9. doi: 10.1007/s12016-007-8023-4. Clin Rev Allergy Immunol. 2008. PMID: 18270857 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials